PHARMACEUTICALLY ACTIVE COMPOUNDS

摘要

The present invention relates to compounds of formula I: wherein R and R are as defined herein or a pharmaceutically acceptable salt or solvate thereof. The compounds of formula I are inhibitors of aurora kinase and/or FLT3. The present invention also relates to processes for the preparation of these compounds to pharmaceutical compositions comprising them and to their use in the treatment of proliferative disorders such as cancer as well as other diseases or conditions in which aurora kinase and/or FLT3 activity is implicated.